This site is intended for Healthcare professionals only.

Stryker to buy Entellus Medical for 662 million dollars

Stryker to buy Entellus Medical for 662 million dollars

Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose, and throat (ENT) business.

Stryker would pay $24 per Entellus share, a premium of about 50 percent to Entellus’s Wednesday close. Entellus shares jumped 53.7 percent to $24.60 in premarket trading.

Plymouth, Minnesota-based Entellus designs minimally invasive products for the treatment of various ENT diseases. The company generated revenue of $23 million in the third quarter.

Entellus’s portfolio of ENT devices like dilation system XprESS and nasal implant Latera would complement its instrument business, Stryker said.

The deal is expected to be dilutive to Stryker’s 2018 adjusted net earnings by about 4 cents per share, but accretive thereafter, the company said.

Guggenheim Securities was financial adviser to Stryker, while Piper Jaffray & Co advised Entellus.

(Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)

The following two tabs change content below.
Ruby Khatun

Ruby Khatun

Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at Contact no. 011-43720751

0 comment(s) on Stryker to buy Entellus Medical for 662 million dollars

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted